136 related articles for article (PubMed ID: 17194554)
41. Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women.
Schwartz AG; Wenzlaff AS; Prysak GM; Murphy V; Cote ML; Brooks SC; Skafar DF; Lonardo F
J Clin Oncol; 2007 Dec; 25(36):5785-92. PubMed ID: 18089876
[TBL] [Abstract][Full Text] [Related]
42. Lack of evidence for effect modification by estrogen of association between body mass index and colorectal cancer risk among postmenopausal women.
Wang Y; Jacobs EJ; Teras LR; Pavluck AL; Rodriguez C; Thun MJ; Calle EE
Cancer Causes Control; 2007 Oct; 18(8):793-9. PubMed ID: 17619155
[TBL] [Abstract][Full Text] [Related]
43. Differential dietary nutrient intake according to hormone replacement therapy use: an underestimated confounding factor in epidemiologic studies?
Vercambre MN; Fournier A; Boutron-Ruault MC; Clavel-Chapelon F; Ringa V; Berr C
Am J Epidemiol; 2007 Dec; 166(12):1451-60. PubMed ID: 17698505
[TBL] [Abstract][Full Text] [Related]
44. The incidence of breast cancer and changes in the use of hormone replacement therapy: a review of the evidence.
Verkooijen HM; Bouchardy C; Vinh-Hung V; Rapiti E; Hartman M
Maturitas; 2009 Oct; 64(2):80-5. PubMed ID: 19709827
[TBL] [Abstract][Full Text] [Related]
45. Past oral contraceptive and hormone therapy use and endogenous hormone concentrations in postmenopausal women.
Chan MF; Dowsett M; Folkerd E; Wareham N; Luben R; Welch A; Bingham S; Khaw KT
Menopause; 2008; 15(2):332-9. PubMed ID: 17667152
[TBL] [Abstract][Full Text] [Related]
46. Menopause characteristics of women with physical disabilities from poliomyelitis.
Kalpakjian CZ; Quint EH; Tate DG; Roller S; Toussaint LL
Maturitas; 2007 Feb; 56(2):161-72. PubMed ID: 16930875
[TBL] [Abstract][Full Text] [Related]
47. Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy.
Schuetz F; Diel IJ; Pueschel M; von Holst T; Solomayer EF; Lange S; Sinn P; Bastert G; Sohn C
Am J Obstet Gynecol; 2007 Apr; 196(4):342.e1-9. PubMed ID: 17403414
[TBL] [Abstract][Full Text] [Related]
48. Use of hormone replacement therapy, 1998-2007: sustained impact of the Women's Health Initiative findings.
Silverman BG; Kokia ES
Ann Pharmacother; 2009 Feb; 43(2):251-8. PubMed ID: 19193581
[TBL] [Abstract][Full Text] [Related]
49. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
Shantakumar S; Terry MB; Paykin A; Teitelbaum SL; Britton JA; Moorman PG; Kritchevsky SB; Neugut AI; Gammon MD
Am J Epidemiol; 2007 May; 165(10):1187-98. PubMed ID: 17337757
[TBL] [Abstract][Full Text] [Related]
50. Hormone replacement therapy and survival in lung cancer in postmenopausal women in a rural population.
Huang B; Carloss H; Wyatt SW; Riley E
Cancer; 2009 Sep; 115(18):4167-75. PubMed ID: 19526591
[TBL] [Abstract][Full Text] [Related]
51. Prevalence and determinants of hormone replacement therapy in German women 1984-1995.
Mueller JE; Döring A; Heier M; Löwel H
Maturitas; 2002 Oct; 43(2):95-104. PubMed ID: 12385857
[TBL] [Abstract][Full Text] [Related]
52. Effects of postmenopausal hormone replacement therapy on body fat composition.
Yüksel H; Odabasi AR; Demircan S; Köseoğlu K; Kizilkaya K; Onur E
Gynecol Endocrinol; 2007 Feb; 23(2):99-104. PubMed ID: 17454160
[TBL] [Abstract][Full Text] [Related]
53. The evolution of educational inequalities in smoking: a changing relationship and a cross-over effect among German birth cohorts of 1921-70.
Schulze A; Mons U
Addiction; 2006 Jul; 101(7):1051-6. PubMed ID: 16771897
[TBL] [Abstract][Full Text] [Related]
54. Participants and refusers in a telephone interview about hormone replacement therapy were equally likely to be taking it.
Strom BL; Schinnar R
J Clin Epidemiol; 2004 Jun; 57(6):624-6. PubMed ID: 15246131
[TBL] [Abstract][Full Text] [Related]
55. Current trends in hormone replacement therapy: perceptions and usage.
Birkhäuser MH; Reinecke I
Climacteric; 2008 Jun; 11(3):192-200. PubMed ID: 18568784
[TBL] [Abstract][Full Text] [Related]
56. The menopause symptom profile of Maori and non-Maori women in New Zealand.
Lawton BA; Rose SB; Cormack DM; Stanley J; Dowell AC
Climacteric; 2008; 11(6):467-74. PubMed ID: 18802815
[TBL] [Abstract][Full Text] [Related]
57. Potentially modifiable classic risk factors and their impact on incident myocardial infarction: results from the EPIC-Potsdam study.
Heidemann C; Hoffmann K; Klipstein-Grobusch K; Weikert C; Pischon T; Hense HW; Boeing H
Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):65-71. PubMed ID: 17301629
[TBL] [Abstract][Full Text] [Related]
58. Patterns of hormone therapy use in the Norwegian Women and Cancer study (NOWAC) 1996-2005.
Waaseth M; Bakken K; Lund E
Maturitas; 2009 Jul; 63(3):220-6. PubMed ID: 19394168
[TBL] [Abstract][Full Text] [Related]
59. Breast cancer incidence and hormone replacement therapy: results from the MISSION study, prospective phase.
Espié M; Daures JP; Chevallier T; Mares P; Micheletti MC; De Reilhac P
Gynecol Endocrinol; 2007 Jul; 23(7):391-7. PubMed ID: 17701770
[TBL] [Abstract][Full Text] [Related]
60. Patterns of past alcohol consumption in the EPIC-Germany cohorts. European Investigation into Cancer and Nutrition.
Klipstein-Grobusch K; Becker N; Kroke A; Boeing H
Ann Nutr Metab; 1999; 43(4):258-65. PubMed ID: 10592374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
